Soligenix Appoints Former White House Economic Adviser Tomas J. Philipson as Strategic Advisor

Soligenix, a biopharmaceutical company, has appointed Tomas J. Philipson, PhD, as a strategic advisor. Philipson is an expert in US economic policy and healthcare policy, with a background in government service, including as vice chairman of President Trump's White House Council of Economic Advisers. He brings a broad range of expertise and a network to the role, contributing to Soligenix's efforts to develop and commercialize products for rare diseases.